94 related articles for article (PubMed ID: 16384842)
1. Estrogen metabolites and systolic blood pressure in a population-based sample of postmenopausal women.
Masi CM; Hawkley LC; Berry JD; Cacioppo JT
J Clin Endocrinol Metab; 2006 Mar; 91(3):1015-20. PubMed ID: 16384842
[TBL] [Abstract][Full Text] [Related]
2. Serum estrogen metabolites and systolic blood pressure among middle-aged and older women and men.
Masi CM; Hawkley LC; Xu X; Veenstra TD; Cacioppo JT
Am J Hypertens; 2009 Nov; 22(11):1148-53. PubMed ID: 19713943
[TBL] [Abstract][Full Text] [Related]
3. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?
Ursin G; Wilson M; Henderson BE; Kolonel LN; Monroe K; Lee HP; Seow A; Yu MC; Stanczyk FZ; Gentzschein E
Cancer Res; 2001 Apr; 61(8):3326-9. PubMed ID: 11309288
[TBL] [Abstract][Full Text] [Related]
4. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women.
Wu WH; Lu SC; Wang TF; Jou HJ; Wang TA
Eur J Clin Nutr; 2006 Mar; 60(3):386-92. PubMed ID: 16278686
[TBL] [Abstract][Full Text] [Related]
5. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
[TBL] [Abstract][Full Text] [Related]
6. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
Jernström H; Klug TL; Sepkovic DW; Bradlow HL; Narod SA
Carcinogenesis; 2003 May; 24(5):991-1005. PubMed ID: 12771045
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
10. Dietary fiber and serum 16α-hydroxyestrone, an estrogen metabolite associated with lower systolic blood pressure.
Patel S; Hawkley LC; Cacioppo JT; Masi CM
Nutrition; 2011; 27(7-8):778-81. PubMed ID: 21035306
[TBL] [Abstract][Full Text] [Related]
11. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
12. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer.
Dalessandri KM; Firestone GL; Fitch MD; Bradlow HL; Bjeldanes LF
Nutr Cancer; 2004; 50(2):161-7. PubMed ID: 15623462
[TBL] [Abstract][Full Text] [Related]
13. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women.
Sturgeon SR; Volpe SL; Puleo E; Bertone-Johnson ER; Heersink J; Sabelawski S; Wahala K; Bigelow C; Kurzer MS
Nutr Cancer; 2010; 62(2):175-80. PubMed ID: 20099191
[TBL] [Abstract][Full Text] [Related]
14. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension.
Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C
Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542
[TBL] [Abstract][Full Text] [Related]
15. Estradiol metabolism during oral and transdermal estradiol replacement therapy in postmenopausal women.
Lippert TH; Seeger H; Mueck AO
Horm Metab Res; 1998 Sep; 30(9):598-600. PubMed ID: 9808331
[TBL] [Abstract][Full Text] [Related]
16. Urinary estrogen metabolites and their ratio among Asian American women.
Falk RT; Fears TR; Xu X; Hoover RN; Pike MC; Wu AH; Nomura AM; Kolonel LN; West DW; Sepkovic DW; Bradlow HL; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):221-6. PubMed ID: 15668498
[TBL] [Abstract][Full Text] [Related]
17. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W
Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724
[TBL] [Abstract][Full Text] [Related]
18. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
[TBL] [Abstract][Full Text] [Related]
19. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
